Moritz Helmstaedter is director of the connectomics department at the Max Planck Institute for Brain Research in Frankfurt, Germany.

Moritz Helmstaedter
Director, Department of Connectomics
Max Planck Institute for Brain Research
From this contributor
Of mice and human interneurons: Q&A with Moritz Helmstaedter
People’s brains have a larger network of inhibitory interneurons than mouse brains do, according to a new study. Changes to that network could contribute to autism or other conditions, says lead investigator Moritz Helmstaedter.

Of mice and human interneurons: Q&A with Moritz Helmstaedter
Explore more from The Transmitter
Building the future of neuroscience at HBCUs
Black In Neuro is launching a new program to help historically Black colleges and universities advance neuroscience research and education, focusing on cross-institutional collaboration, joint curriculum development and improved mentoring initiatives.

Building the future of neuroscience at HBCUs
Black In Neuro is launching a new program to help historically Black colleges and universities advance neuroscience research and education, focusing on cross-institutional collaboration, joint curriculum development and improved mentoring initiatives.
Emotion research has a communication conundrum
In 2025, the words we use to describe emotions matter, but their definitions are controversial. Here, I unpack the different positions in this space and the rationales behind them—and I invite 13 experts to chime in.

Emotion research has a communication conundrum
In 2025, the words we use to describe emotions matter, but their definitions are controversial. Here, I unpack the different positions in this space and the rationales behind them—and I invite 13 experts to chime in.
Autism-linked copy number variants always boost autism likelihood
By contrast, varied doses of the same genes decrease or increase the odds of five other conditions, with distinct biological consequences, two new preprints show.

Autism-linked copy number variants always boost autism likelihood
By contrast, varied doses of the same genes decrease or increase the odds of five other conditions, with distinct biological consequences, two new preprints show.